1. Home
  2. FSUN vs ANAB Comparison

FSUN vs ANAB Comparison

Compare FSUN & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$35.52

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$55.70

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
ANAB
Founded
1892
2005
Country
United States
United States
Employees
1186
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FSUN
ANAB
Price
$35.52
$55.70
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$45.00
$71.67
AVG Volume (30 Days)
141.0K
501.3K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.02
EPS
N/A
N/A
Revenue
N/A
$234,603,000.00
Revenue This Year
$79.34
N/A
Revenue Next Year
$14.67
$52.14
P/E Ratio
$11.30
N/A
Revenue Growth
N/A
157.01
52 Week Low
$29.95
$17.11
52 Week High
$42.34
$73.30

Technical Indicators

Market Signals
Indicator
FSUN
ANAB
Relative Strength Index (RSI) 44.25 37.43
Support Level $34.44 $53.46
Resistance Level $37.12 $57.70
Average True Range (ATR) 0.87 3.58
MACD 0.03 -0.90
Stochastic Oscillator 38.49 5.35

Price Performance

Historical Comparison
FSUN
ANAB

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments; Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: